(Q41927491)

14 October 2017

title

Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus (English)

1 reference

14 October 2017

1 reference

Yoko Momose

1

1 reference

14 October 2017

Satoru Arai

2

1 reference

14 October 2017

Hikaru Eto

3

1 reference

14 October 2017

Mitsumasa Kishimoto

4

1 reference

14 October 2017

Masato Okada

5

1 reference

14 October 2017

publication date

6 December 2012

1 reference

The Journal of Dermatology

14 October 2017

published in

1 reference

14 October 2017

volume

40

1 reference

14 October 2017

issue

2

1 reference

14 October 2017

page(s)

94-97

1 reference

Cutaneous lupus erythematosus: Update of therapeutic options

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12005

Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12005

Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12005

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12005

Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12005

Hydroxychloroquine administration for Japanese lupus erythematosus in Wakayama: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12005

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12005

Systematic administration of chloroquine in discoid lupus erythematosus reduces skin lesions via inhibition of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.12005

21 January 2018

Identifiers

DOI

10.1111/1346-8138.12005

1 reference

14 October 2017

1 reference